Cargando…
Improved screening of the cardiovascular safety of COVID-19 anti-viral compounds
Autores principales: | Maddock, Helen, Hurst, Josh, Linekar, Adam, Wallis, Rob, Billson, Jeremy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483624/ http://dx.doi.org/10.1016/j.vascn.2021.107047 |
Ejemplares similares
-
Anti-cancer Therapy Leads to Increased Cardiovascular Susceptibility to COVID-19
por: Lozahic, Caroline, et al.
Publicado: (2021) -
Profiling the Biomechanical Responses to Workload on the Human Myocyte to Explore the Concept of Myocardial Fatigue and Reversibility: Rationale and Design of the POWER Heart Failure Study
por: Tran, Patrick, et al.
Publicado: (2023) -
The cardiac work-loop technique: An in vitro model for identifying and profiling drug-induced changes in inotropy using rat papillary muscles
por: Fletcher, Sophie, et al.
Publicado: (2020) -
Filtration Improves the Performance of a High-Throughput Screen for Anti-Mycobacterial Compounds
por: Cheng, Nancy, et al.
Publicado: (2014) -
A Targeted Computational Screen of the SWEETLEAD Database Reveals FDA-Approved Compounds with Anti-Dengue Viral Activity
por: Moshiri, Jasmine, et al.
Publicado: (2020)